688075 安旭生物
按盤價 
35.760 -0.540 (-1.488%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.201 | 1.339 | 3.729 | 2.688 | 75.847 |
| 總資產報酬率 ROA (%) | -0.181 | 1.213 | 3.327 | 2.222 | 59.516 |
| 投入資產回報率 ROIC (%) | -0.191 | 1.295 | 3.573 | 2.529 | 70.577 | 邊際利潤分析 |
| 銷售毛利率 (%) | 40.800 | 42.504 | 39.102 | 42.298 | 74.782 |
| 營業利潤率 (%) | -19.897 | 15.417 | 38.392 | 33.273 | 57.232 |
| 息稅前利潤/營業總收入 (%) | 34.231 | 29.334 | 31.859 | 14.479 | 48.426 |
| 淨利潤/營業總收入 (%) | -14.543 | 15.337 | 35.553 | 28.005 | 49.371 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 351.098 | -106.655 | 18.315 | 42.170 | 119.289 |
| 價值變動淨收益/利潤總額(%) | -220.195 | 206.725 | 86.232 | 59.315 | 1.392 |
| 營業外收支淨額/利潤總額(%) | -0.171 | 7.081 | 1.451 | -16.457 | -0.265 | 償債能力分析 |
| 流動比率 (X) | 8.873 | 10.504 | 10.035 | 8.788 | 4.569 |
| 速動比率 (X) | 8.612 | 10.199 | 9.726 | 8.428 | 4.424 |
| 資產負債率 (%) | 10.622 | 9.090 | 9.872 | 11.811 | 22.044 |
| 帶息債務/全部投入資本 (%) | 4.662 | 1.798 | 1.577 | 2.489 | 3.782 |
| 股東權益/帶息債務 (%) | 2,012.940 | 5,380.705 | 6,128.453 | 3,815.547 | 2,465.186 |
| 股東權益/負債合計 (%) | 842.137 | 1,000.923 | 913.676 | 747.187 | 353.842 |
| 利息保障倍數 (X) | 0.633 | 2.302 | -4.489 | -1.027 | -5.596 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 236.785 | 155.867 | 133.025 | 155.982 | 22.029 |
| 存貨周轉天數 (天) | 290.061 | 194.609 | 188.213 | 244.442 | 51.010 |
| 備註： | 即時報價更新時間為 27/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
